Want to see HK:1332 full AI Analyst Report?
1332 Stock Chart & Stats
HK$0.21
<HK$0.01(2.59%)
At close: 4:00 PM EST
HK$0.21
<HK$0.01(2.59%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.75
Previous CloseN/A
Volume50.63K
Average Volume (3M)1.17M
Market Cap
HK$451.06M
Enterprise ValueHK$1.03K
Total Cash (Recent Filing)HK$4.39M
Total Debt (Recent Filing)HK$482.12M
Price to Earnings (P/E)2.4
Beta-0.14
Next Earnings
Apr 01, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding2,928,952,100
10 Day Avg. Volume1,014,343
30 Day Avg. Volume1,173,906
Financial Highlights & Ratios
PEG Ratio-1.74
Price to Book (P/B)-14.01
Price to Sales (P/S)10.69
P/FCF Ratio-21.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Net IncomeThe return to positive net income provides some evidence that non-operating gains or other items improved reported earnings in 2025. However, because EBIT and EBITDA remained deeply negative, this is a limited and lower-quality improvement that does not yet demonstrate a durable turnaround in the core business.
Narrower Free Cash Flow LossA narrower free cash flow deficit indicates some year-over-year improvement in cash consumption and could modestly reduce immediate funding pressure. The benefit remains limited because free cash flow was still negative, so the company has not yet shown self-funding operations or sustainable cash generation.
Prior Positive Equity BaseThe company previously maintained positive shareholders’ equity and more manageable leverage, showing that a healthier capital structure has existed historically. This offers evidence of prior balance-sheet capacity, although the subsequent deterioration means it is not currently a dependable source of financial strength.
Bears Say
Severe Revenue ContractionRepeated revenue contraction signals weakening demand, shrinking scale, or loss of business momentum rather than a temporary quarterly fluctuation. A smaller revenue base reduces operating leverage, limits reinvestment capacity, and makes it harder for the company to absorb fixed costs or restore profitability over the next several quarters.
Persistent Operating LossesDeeply negative EBIT and EBITDA show that the core operations are not covering their operating costs, making the business model economically unsustainable at its current scale. Without a material improvement in revenue quality or cost structure, recurring operating losses will continue to weaken liquidity and constrain strategic execution.
Stressed Balance SheetNegative equity combined with substantial debt indicates a highly leveraged and financially fragile capital structure. This reduces flexibility to fund growth internally, raises refinancing and restructuring risk, and leaves the company less able to withstand continued operating losses or a prolonged revenue decline.
China Touyun Tech Group News
1332 FAQ
What was China Touyun Tech Group Ltd’s price range in the past 12 months?
China Touyun Tech Group Ltd lowest stock price was HK$0.07 and its highest was HK$0.75 in the past 12 months.
What is China Touyun Tech Group Ltd’s market cap?
China Touyun Tech Group Ltd’s market cap is HK$451.06M.
When is China Touyun Tech Group Ltd’s upcoming earnings report date?
China Touyun Tech Group Ltd’s upcoming earnings report date is Apr 01, 2027 which is in 182 days.
How were China Touyun Tech Group Ltd’s earnings last quarter?
China Touyun Tech Group Ltd released its earnings results on Aug 28, 2026. The company reported HK$0.07 earnings per share for the quarter.
Is China Touyun Tech Group Ltd overvalued?
According to Wall Street analysts China Touyun Tech Group Ltd’s price is currently Overvalued.
Does China Touyun Tech Group Ltd pay dividends?
China Touyun Tech Group Ltd does not currently pay dividends.
What is China Touyun Tech Group Ltd’s EPS estimate?
China Touyun Tech Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Touyun Tech Group Ltd have?
China Touyun Tech Group Ltd has 2,928,952,100 shares outstanding.
What happened to China Touyun Tech Group Ltd’s price movement after its last earnings report?
China Touyun Tech Group Ltd reported an EPS of HK$0.07 in its last earnings report. Following the earnings report the stock price went up 0.599%.
Which hedge fund is a major shareholder of China Touyun Tech Group Ltd?
Currently, no hedge funds are holding shares in HK:1332
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Touyun Tech Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
59.37%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Touyun Tech Group Ltd
Touyun Biotech Group Limited functions as a diversified investment holding company, primarily focused on the global design, development, manufacturing, and sale of a wide array of packaging products. Its market presence extends across Hong Kong, the People's Republic of China, Europe, North and South America, and other international territories. The company's operations are divided into four main business segments. The QR Code Business provides comprehensive solutions, including QR codes for product packaging and advertising display services. The Packaging Products segment specializes in creating and selling items such as luxury watch and jewelry boxes, eyewear cases, various bags and pouches, and retail display units. The Treasury Investment segment is engaged in the investment and trading of securities, alongside offering financial services like money lending, placing and underwriting, securities brokerage, asset management, and margin financing. Additionally, the Chlamydomonas Reinhardtii Product Business segment focuses on cultivating and marketing Chlamydomonas reinhardtii micro-algae and associated products. Beyond these core activities, the group also offers business intelligence IT solutions, online advertising display, and corporate management services. Established in 1989 and headquartered in Wan Chai, Hong Kong, the company transitioned to its current name, Touyun Biotech Group Limited, in May 2021, having previously been known as China Touyun Tech Group Limited.
Technical Analysis
Greatview Aseptic Packaging Company
―
Singamas Container Holdings
―
Pacific Millennium Packaging Group Corp.
―
China Aluminum Cans Holdings Ltd.
―
Wan Cheng Metal Packaging Company Limited
―